ALLEGRA
Pronunciation: fex-oe-FEN-a-deen (a-LE-gra)


What it isSecond-generation H1 antagonist and P-gp substrate; allergic rhinitis and urticaria.
Why this oneActively excluded from the CNS by P-gp, making it the least sedating antihistamine.
What limits itFruit juice reduces absorption substantially through OATP inhibition. Cations block it; renally adjusted.
Animated chart of estimated U.S. prescriptions per year, H1 antihistamines (1944–2026). Fexofenadine enters in 1996 (estimated).
Principal riskFruit juice substantially reduces absorption
Legacy pregnancy categoryC
Defining liabilityReduced absorption with fruit juice; renal dosing considerations
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Allergy relief | ≥12 yr | 18 mg QD | 1 tablet/24h |
Renal Undefined
Hepatic Undefined
Available strengths
Pregnancy Undefined
Lactation Undefined
Open Fexofenadine in the interactive console ↗